跳至主要内容
临床试验/CTRI/2022/05/042700
CTRI/2022/05/042700已完成2 期

A randomized clinical trial on the comparative efficacy of Gandharyadi Ghrita Nasya and Dashmooladi Ghrita Nasya along with Dhatryadi Ghan Vati orally in Ardhavabhedaka with special reference to Migraine

ational Institute of Ayurveda Jaipur0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients willing to participate in this trial through written informed consent.
  • 2.Both fresh and treated patients.
  • 3.Patients between18 to 60 years of age from either sex.
  • 4.Patients presenting with symptoms of Ardhavabhedaka vis-à-vis Migraine.

排除标准

  • 1.Patients of age less than 18 and greater than 60
  • 2.Patients with referred pain in one half of head due to other secondary reasons such as anxiety, refractive errors etc. rather than migraine.
  • 3.Patients with complicated Migraine like hemiplegic migraine and having any chronic debilitating disease with other neurological pathology.
  • 4.Pregnant and lactating women.
  • 5.Patients suffering from any other major systemic disorders which interfare with course of treatment.

研究者

发起方
ational Institute of Ayurveda Jaipur

相似试验